Blog

Cathy Eng: Beyond the headlines, The Real Impact of Early-Onset Cancers

Cathy Eng/X

Jun 3, 2025, 12:44

Cathy Eng: Beyond the headlines, The Real Impact of Early-Onset Cancers

Cathy Eng, Associate Director of Strategic Relations and Research Partners and Co-Leader of the Gastrointestinal Cancer Research Program at the Vanderbilt-Ingram Cancer Center, shared a post on X:

“It was so wonderful to be able to participate in this ASCO session “Beyond the headlines: The Real Impact of Early-Onset Cancers”.Kimryn Rathmell, Katie Coleman, LeeAnne Bailey, Andrew Chang, NCI Cancer Trials, Mass General.”

Cathy Eng shared her involvement in an ASCO session focused on the real-world effects of early-onset cancers. The discussion featured multiple experts, highlighting diverse perspectives from institutions including NCI and Mass General.

More posts featuring Cathy Eng.

Andrew Chang ASCO25 cancer Cathy Eng fight against cancer gastrointestinal cancer Global fight against cancer Katie Coleman Kimryn Rathmell LeeAnne Bailey Mass General NCI Cancer Trials OncoDaily Oncology Vanderbilt-Ingram Cancer Center

Agenus and Zydus Group Announced a $141M Strategic Collaboration to Advance the Manufacturing and Global Development of BOT/BAL

15 Posts Not to Miss from the 4th Day of ASCO 2025

15 Posts Not to Miss from the 3rd Day of ASCO 2025

MATTERHORN Trial at ASCO 2025: Durvalumab plus FLOT Shows Significant Improvement of EFS in Resectable Gastric and GEJ Cancer Treatment

15 Posts Not to Miss from the 2nd Day of ASCO 2025